Donna R Roberts1,2, Heather R Collins3, Jessica K Lee4,5, James A Taylor3, Matthew Turner3, Greg Zaharchuk6, Max Wintermark6, Michael U Antonucci3, Edwin R Mulder4, Darius A Gerlach4, Davud Asemani3, Heather R McGregor5, Rachael D Seidler5,7. 1. Department of Radiology and Radiological Science, Medical University of South Carolina, Charleston, SC, USA. robertdr@musc.edu. 2. Department of Neuroscience, Medical University of South Carolina, Charleston, SC, USA. robertdr@musc.edu. 3. Department of Radiology and Radiological Science, Medical University of South Carolina, Charleston, SC, USA. 4. German Aerospace Center (DLR, Institute of Aerospace Medicine), Cologne, Germany. 5. Department of Applied Physiology and Kinesiology, College of Health and Human Performance, University of Florida, Gainesville, FL, USA. 6. Department of Radiology, Division of Neuroradiology, Stanford University, Stanford, CA, USA. 7. Norman Fixel Institute for Neurological Diseases, College of Health and Human Performance, University of Florida, Gainesville, FL, USA.
Abstract
PURPOSE: Following prolonged stays on the International Space Station (ISS), some astronauts exhibit visual acuity changes, ophthalmological findings, and mildly elevated intracranial pressures as part of a novel process called spaceflight-associated neuro-ocular syndrome (SANS). To determine the pathophysiology of SANS, NASA conducted a multi-investigator study in which 11 healthy participants underwent head-down tilt bed rest, mimicking microgravity-induced cephalad fluid shifts, combined with elevated ambient CO2 levels similar to those on the ISS (HDT+CO2). As part of that study, we examined the effects of HDT+CO2 on cerebral perfusion. METHODS: Using arterial spin labeling, we compared cerebral perfusion before, during, and after HDT+CO2 in participants who developed SANS (n = 5) with those who did not (n = 6). RESULTS: All participants demonstrated a decrease in perfusion during HDT+CO2 (mean decrease of 25.1% at HDT7 and 16.2% at HDT29); however, the timing and degree of change varied between the groups. At day 7 of HDT+CO2, the SANS group experienced a greater reduction in perfusion than the non-SANS group (p =.05, 95% CI:-0.19 to 16.11, d=.94, large effect). Conversely, by day 29 of HDT+CO2, the SANS group had significantly higher perfusion (approaching their baseline) than the non-SANS group (p = .04, 95% CI:0.33 to 13.07, d=1.01, large effect). CONCLUSION: Compared with baseline and recovery, HDT+CO2 resulted in reduced cerebral perfusion which varied based on SANS status. Further studies are needed to unravel the relative role of HDT vs hypercapnia, to determine if these perfusion changes are clinically relevant, and whether perfusion changes contribute to the development of SANS during spaceflight.
PURPOSE: Following prolonged stays on the International Space Station (ISS), some astronauts exhibit visual acuity changes, ophthalmological findings, and mildly elevated intracranial pressures as part of a novel process called spaceflight-associated neuro-ocular syndrome (SANS). To determine the pathophysiology of SANS, NASA conducted a multi-investigator study in which 11 healthy participants underwent head-down tilt bed rest, mimicking microgravity-induced cephalad fluid shifts, combined with elevated ambient CO2 levels similar to those on the ISS (HDT+CO2). As part of that study, we examined the effects of HDT+CO2 on cerebral perfusion. METHODS: Using arterial spin labeling, we compared cerebral perfusion before, during, and after HDT+CO2 in participants who developed SANS (n = 5) with those who did not (n = 6). RESULTS: All participants demonstrated a decrease in perfusion during HDT+CO2 (mean decrease of 25.1% at HDT7 and 16.2% at HDT29); however, the timing and degree of change varied between the groups. At day 7 of HDT+CO2, the SANS group experienced a greater reduction in perfusion than the non-SANS group (p =.05, 95% CI:-0.19 to 16.11, d=.94, large effect). Conversely, by day 29 of HDT+CO2, the SANS group had significantly higher perfusion (approaching their baseline) than the non-SANS group (p = .04, 95% CI:0.33 to 13.07, d=1.01, large effect). CONCLUSION: Compared with baseline and recovery, HDT+CO2 resulted in reduced cerebral perfusion which varied based on SANS status. Further studies are needed to unravel the relative role of HDT vs hypercapnia, to determine if these perfusion changes are clinically relevant, and whether perfusion changes contribute to the development of SANS during spaceflight.
Authors: Thomas H Mader; C Robert Gibson; Anastas F Pass; Larry A Kramer; Andrew G Lee; Jennifer Fogarty; William J Tarver; Joseph P Dervay; Douglas R Hamilton; Ashot Sargsyan; John L Phillips; Duc Tran; William Lipsky; Jung Choi; Claudia Stern; Raffi Kuyumjian; James D Polk Journal: Ophthalmology Date: 2011-08-17 Impact factor: 12.079
Authors: Steven S Laurie; Brandon R Macias; Jocelyn T Dunn; Millennia Young; Claudia Stern; Stuart M C Lee; Michael B Stenger Journal: Ophthalmology Date: 2018-10-09 Impact factor: 12.079
Authors: Angelique Van Ombergen; Steven Jillings; Ben Jeurissen; Elena Tomilovskaya; R Maxine Rühl; Alena Rumshiskaya; Inna Nosikova; Liudmila Litvinova; Jitka Annen; Ekaterina V Pechenkova; Inessa B Kozlovskaya; Stefan Sunaert; Paul M Parizel; Valentin Sinitsyn; Steven Laureys; Jan Sijbers; Peter Zu Eulenburg; Floris L Wuyts Journal: N Engl J Med Date: 2018-10-25 Impact factor: 91.245
Authors: Jessica K Lee; Vincent Koppelmans; Roy F Riascos; Khader M Hasan; Ofer Pasternak; Ajitkumar P Mulavara; Jacob J Bloomberg; Rachael D Seidler Journal: JAMA Neurol Date: 2019-04-01 Impact factor: 18.302
Authors: Donna R Roberts; Moritz H Albrecht; Heather R Collins; Davud Asemani; A Rano Chatterjee; M Vittoria Spampinato; Xun Zhu; Marc I Chimowitz; Michael U Antonucci Journal: N Engl J Med Date: 2017-11-02 Impact factor: 91.245
Authors: Jennifer Law; Mary Van Baalen; Millennia Foy; Sara S Mason; Claudia Mendez; Mary L Wear; Valerie E Meyers; David Alexander Journal: J Occup Environ Med Date: 2014-05 Impact factor: 2.162
Authors: Giovanni Taibbi; Ronita L Cromwell; Susana B Zanello; Patrice O Yarbough; Robert J Ploutz-Snyder; Bernard F Godley; Gianmarco Vizzeri Journal: Aviat Space Environ Med Date: 2014-10
Authors: Vincent Koppelmans; Jacob J Bloomberg; Ajitkumar P Mulavara; Rachael D Seidler Journal: NPJ Microgravity Date: 2016-12-19 Impact factor: 4.415
Authors: Angelique Van Ombergen; Steven Jillings; Ben Jeurissen; Elena Tomilovskaya; Alena Rumshiskaya; Liudmila Litvinova; Inna Nosikova; Ekaterina Pechenkova; Ilya Rukavishnikov; Olga Manko; Sergey Danylichev; R Maxine Rühl; Inessa B Kozlovskaya; Stefan Sunaert; Paul M Parizel; Valentin Sinitsyn; Steven Laureys; Jan Sijbers; Peter Zu Eulenburg; Floris L Wuyts Journal: Proc Natl Acad Sci U S A Date: 2019-05-06 Impact factor: 11.205
Authors: Giuseppe Barisano; Elena Tomilovskaya; Donna R Roberts; Floris L Wuyts Journal: Proc Natl Acad Sci U S A Date: 2022-07-18 Impact factor: 12.779
Authors: Heather R McGregor; Jessica K Lee; Edwin R Mulder; Yiri E De Dios; Nichole E Beltran; Igor S Kofman; Jacob J Bloomberg; Ajitkumar P Mulavara; Scott M Smith; Sara R Zwart; Rachael D Seidler Journal: Hum Brain Mapp Date: 2021-06-09 Impact factor: 5.399